This study will evaluate the immunogenicity of rabies vaccine at 13 months, 3 year and 5 years after initial vaccination, administered in two different post-exposure vaccination schedules

Inclusion Criteria:

• Male and Female subjects who received complete vaccine series in accordance to the designated vaccination schedule in the previous M49P8 study

Exclusion Criteria:

• Any disease condition, that in the opinion of investigator may interfere with subjects ability to participate in the study.
• Receipt of additional doses of rabies vaccine after completion of initial vaccine series.
• For additional entry criteria please refer to protocol.

Subjects who received complete vaccine series in accordance to the designated vaccination schedule in the previous M49P8 study